Trials / Enrolling By Invitation
Enrolling By InvitationNCT03123835
Outcome Analysis of POEM and Endoluminal Therapies
Outcome Analysis of Endoluminal Therapies for Gastrointestinal Conditions Compared to Current Treatment Paradigms
- Status
- Enrolling By Invitation
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 500 (estimated)
- Sponsor
- University of California, Davis · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Accepted
Summary
Evaluation of current and newly developed endoluminal therapies in the management of Upper and Lower GI conditions.
Detailed description
Over the last few years there have been numerous advances in the use of endoscopic equipment and related treatments in the identification and intervention of gastrointestinal diseases. Many of these treatments using flexible endoscopes have either complimented or replaced surgical approaches to these same benign and malignant disease processes with the potential of being the standard of care for many of these clinical conditions. The initial primary focus of this study will be the use of endoscopic myotomy for achalasia, endoscopic treatment of post bariatric weight gain, endoscopic gastro-gastric fistula treatments, and other endoluminal therapies for gastrointestinal and post-operative conditions. These treatments have been validated by prior surgery studies.
Conditions
- Achalasia
- Gastric Fistula
- Weight Gain After Primary Weight Loss Surgery
- Marginal Ulcer
- Stenoses
- Gastric Nec
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Endoscopic Intervention | After reviewing all therapeutic options the patient will be offered the best therapeutic option to treat their condition. Surgical interventions include open laparotomy, diagnostic/therapeutic laparoscopy or endoluminal therapies. After the patient is consented for the related surgical intervention the patient will be given the option to participate in the clinical study to measure outcomes after surgery. |
Timeline
- Start date
- 2016-03-01
- Primary completion
- 2030-12-01
- Completion
- 2031-12-01
- First posted
- 2017-04-21
- Last updated
- 2025-12-05
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03123835. Inclusion in this directory is not an endorsement.